4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006532
EVP, Ops & Strategy acquired 271,134 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Donley Matthew Maxwell EVP, Ops & Strategy | 2023-03-02 | Grant or award | +271,134 | 403,141 | D |
Loading xslF345X03/wf-form4_167813816425740.xml…